VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MASS908 Devices Inc.
$8.66$327M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMASSP/E History

MASS logo908 Devices Inc. (MASS) P/E Ratio History

Expensive

Trading at 16.0x vs 5Y avg 9.5x · 100th percentile · Material premium to history · Data 2025–2025

Current P/E (TTM)
16.0x
+68% vs 5Y avg
5Y Avg P/E
9.5x
Median 9.5x
5Y Percentile
100th
Upper end of range
PEG Ratio
N/A
TTM EPS$-0.97
Price$8.66
Earnings Yield6.24%
EPS Growth (1Y)125.5%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, 908 Devices Inc. (MASS) trades at a price-to-earnings ratio of 16.0x, with a stock price of $8.66 and trailing twelve-month earnings per share of $-0.97.

The current P/E is 68% above its 5-year average of 9.5x. Over the past five years, MASS's P/E has ranged from a low of 9.5x to a high of 9.5x, placing the current valuation at the 100th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, MASS trades at a 28% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, MASS trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our MASS DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

MASS Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
16.0vs22.1
-28%
Below Sector
vs. S&P 500
16.0vs24.3
-34%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 125% EPS growth (1Y)

MASS P/E vs Peers

Device suppliers, distribution, and services peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
WAT logoWATWaters Corporation
$23B33.36.38+0%
A logoAAgilent Technologies, Inc.
$36B27.71.89+3%
TMO logoTMOThermo Fisher Scientific Inc.
$172B26.2Lowest12.40+7%
LECO logoLECOLincoln Electric Holdings, Inc.
$15B29.51.33Best+14%
DHR logoDHRDanaher Corporation
$126B35.4--5%
RGEN logoRGENRepligen Corporation
$7B147.2-+287%Best
IDXX logoIDXXIDEXX Laboratories, Inc.
$43B41.73.01+23%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

MASS Historical P/E Data (2025–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Dec 31 2025$5.25$0.559.5x+0%

Average P/E for displayed period: 9.5x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

1+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MASS — Frequently Asked Questions

Quick answers to the most common questions about buying MASS stock.

What is MASS's P/E ratio?

908 Devices Inc. (MASS) trailing twelve-month P/E ratio is 16.0x, based on TTM diluted EPS of $-0.97. The 5-year average P/E is 9.5x and the historical range spans 9.5x to 9.5x.

Is MASS stock overvalued or undervalued?

MASS trades at 16.0x P/E, above its 5-year average of 9.5x. The 100th percentile ranking within the 9.5x–9.5x historical range indicates a premium to historical valuation.

Is MASS stock expensive?

Yes, MASS is expensive relative to its own history. The current P/E of 16.0x is above the 5-year average of 9.5x. The stock sits at the 100th percentile of its 5-year valuation range.

What is MASS's historical P/E range?

Over the past 5 years, MASS's P/E ratio has ranged from 9.5x to 9.5x, with a median of 9.5x and an average of 9.5x. The current P/E of 16.0x places the stock at the 100th percentile of this range. Full historical data spans 2025–2025.

How does MASS's P/E compare to the S&P 500?

MASS trades at 16.0x P/E versus the S&P 500 median of 24.3x. The 34% discount to the market suggests lower growth expectations or perceived higher risk.

How does MASS's valuation compare to Healthcare peers?

908 Devices Inc. P/E of 16.0x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is MASS's PEG ratio?

MASS PEG ratio is N/A, based on a P/E of 16.0x and EPS growth of 125.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is MASS's earnings yield?

MASS earnings yield is 6.24%, the inverse of its 16.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

MASS P/E Ratio History (2025–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current9.5x
Period Avg9.5x
Range9.5x - 9.5x
Change+0%
1 quartersDec 31, 2025 - Dec 31, 2025